CareToLive RSS
Subscribe to the CareToLive RSS feed for up to date news and developments surrounding the legal battle against the FDA and more. (RSS feed reader required)
Subscribe to the CareToLive RSS feed for up to date news and developments surrounding the legal battle against the FDA and more. (RSS feed reader required)
Spread The Word
Please help spread the word about CareToLive. Any of the information found on this website can be distributed and shared freely. We only ask that you provide a link back to this website if you publish our content.
Please help spread the word about CareToLive. Any of the information found on this website can be distributed and shared freely. We only ask that you provide a link back to this website if you publish our content.
Donations
CareToLive is a not for profit corporation; however, donations are NOT tax exempt.
CareToLive is a not for profit corporation; however, donations are NOT tax exempt.
Posts Tagged ‘sloan kettering’
Provenge is approved!
- Provenge has been approved! Thank you to all who helped achieve this important milestone for cancer patients.
LATEST POSTS
- 02/06/2012 - Great Provenge News Released At ASCO
- 11/27/2011 - Care To Live Board Member Ted Girgus Dies of Prostate Cancer
- 09/06/2011 - Care To Live Update on SEC OIG Investigation into April 28, 2009 Dendreon Bear Raid
- 07/13/2011 - 3 Minute Video Explaining Provenge Treatment
- 06/20/2011 - Abigail Alliance Plans FDA PROTEST June 28
- 06/09/2011 - RIP Charles A. Reinwald — Cancer Cure Coalition Founder
- 04/29/2011 - Care To Live Submits Moment of Silence to CMS
- 04/28/2011 - HHS Desperately Needs Transparency Lessons From CMS
- 04/23/2011 - Please Post for Provenge!
- 04/19/2011 - Another Interim Provenge Prostate Cancer Immunotherapy CMS FOIA Response
MOST POPULAR
- Setting the Record Straight
- Provenge Is Approved But The Lies Continue
- Provenge Works & Costs the Same as Chemo & Comments by Bishop
- The Bloodshed, Bogus Threats, Birth Defects, Bashers Cover Letter
- PROVENGE WILL BE COVERED BY MEDICARE
- CareToLive sends a Freedom of Information Request to the Centers for Medicare & Medicaid Services
- ASCO Tells CMS It Should Cover Provenge
- The Centers for Medicare and Medicaid Services are requesting comments.
- Dr. Snuffy Myers Advocates For Provenge Treatment
- Senators Specter and Kerry - CMS Has Some 'Splaining To Do
WHATS GOING ON
This Is An Emergency!
We rallied outside the FDA building in Rockville, Maryland on September 18th. Now there are buses riding around Rockville and Washington, D.C., further protesting the shenanigans that took place inside the FDA building, as well as outside.
The FDA has gotten caught up with Wall Street. While it is supposed to be busy with evaluating food and drugs, its employees just can't keep their eyes off the money. So that is how decisions are being made these days.
This Is An Emergency!
We rallied outside the FDA building in Rockville, Maryland on September 18th. Now there are buses riding around Rockville and Washington, D.C., further protesting the shenanigans that took place inside the FDA building, as well as outside.
The FDA has gotten caught up with Wall Street. While it is supposed to be busy with evaluating food and drugs, its employees just can't keep their eyes off the money. So that is how decisions are being made these days.
WE'LL BE BACK
These people traveled from all across the country to protest outside the FDA Building in Rockville, Maryland. The FDA has stopped a safe and effective treatment from getting to men who need it now. The treatment is called Provenge and it treats men who have late stage prostate cancer.
The FDA appointed a panel of experts to help it decide on the safety and efficacy of Provenge. That panel voted 17-0 that Provenge was safe. And it voted 13-4 that Provenge showed substantial evidence it worked. And yet the FDA delayed it. Now it could be a year, a year and a half or it could be three years. It could be forever.
These people will keeping coming back to Rockville and they hope others will join them until the courts, the FDA, Congress or somebody does something about this travesty.
These people traveled from all across the country to protest outside the FDA Building in Rockville, Maryland. The FDA has stopped a safe and effective treatment from getting to men who need it now. The treatment is called Provenge and it treats men who have late stage prostate cancer.
The FDA appointed a panel of experts to help it decide on the safety and efficacy of Provenge. That panel voted 17-0 that Provenge was safe. And it voted 13-4 that Provenge showed substantial evidence it worked. And yet the FDA delayed it. Now it could be a year, a year and a half or it could be three years. It could be forever.
These people will keeping coming back to Rockville and they hope others will join them until the courts, the FDA, Congress or somebody does something about this travesty.

Care To Live Board Member Ted Girgus Dies of Prostate Cancer
November 27th, 2011 | Posted by CTLTed Girgus, an energetic man who stood up and fought as hard as he could for what he believed in, lost his battle with prostate cancer on Wednesday, November 23rd.
Ted had hoped to be on Provenge way back in 2007.
Here’s Ted protesting for Provenge approval back in 2008:
http://www.youtube.com/watch?v=6Q0uQAL_YDA
Ted could have been rebuilding his immune system all these years had it not been for FDA illegally leaked letters disparaging Provenge right after the Provenge Advisory Committee voted to support approval of Provenge. The panelists voted Provenge SAFE by a count of 17 to 0 and voted Provenge showed SUBSTANTIAL EVIDENCE OF EFFICACY by a count of 13 to 4.
A severely conflicted doctor, namely, Dr. Howard Scher, working out of Sloan Kettering in New York City, spearheaded the delay on many fronts. It is Care To Live’s contention that Scher helped write a letter, along with three other doctors, on behalf of Cougar Biotechnology before the March 29, 2007 panel hearing, in which they begged the FDA not to approve Provenge. At that time Scher did not disclose that he was leading a Novacea Asentar trial and a Cougar Abiraterone trial, both products in competition with Provenge. This explains why he was so active in fighting against Provenge approval during the hearing. After the hearing he worked with Alison Martin from NCI on a letter that was illegally leaked to The Cancer Letter by the FDA. The fact that the Food and Drug Administration (FDA), the National Cancer Institute (NCI), the Department of Justice (DOJ), and Congress, all allowed this malfeasance with impunity, while lives like Ted’s were hanging in the balance, is as despicable an act as any for agencies that supposedly are serving the public.
Ted greatly appreciated Care To Live’s fight for Provenge’s approval. He and his family fought right alongside us. Ted remains forever an exemplary American citizen despite the fact that our government, paid for by his hardworking tax dollars, betrayed him.
Here is an excerpt from the last e-mail Ted wrote to CTL:
Hi Gang,
I’ve been keeping a low profile for awhile due to my new prognosis. My doctors have told me that the cancer has affected my kidneys. I’ve been told that I have about 2 months to live. I will contact the Provenge Site where I live but I think I’m past the point that they will accept me.
I want you all to know how special you have made my life and the purpose you have given me and my family.
The Scriptures tell us it’s not how we start our lives that’s important, it how we end it.
You have filled me with strength and purpose and for that I will always be grateful.
God Bless You All and I know I will see you in heaven!!!
Ted
May you rest in peace, Ted Girgus. Thanks for all you did for Care To Live. You were instrumental in the eventual approval of Provenge, and all cancer patients throughout the world owe you a debt of gratitude.
Popularity: 6%
Tags: Alison Martin, Care To Live, Dendreon, FDA, Howard Scher, NCI, provenge, Richard Pazdur, sloan kettering, Ted Girgus
Posted in The Cause | Post a Comment »
FDA Makes April Fools Out of Men Still Waiting For Provenge
April 1st, 2010 | Posted by CTLSenseless years of death and delay for late stage prostate cancer patients while FDA Honchos collect huge salaries, enjoying life to the fullest.
Popularity: 11%
Tags: Care To Live, CareToLive, Dendreon, FDA, Howard Scher, Immunotherapy, Joel Sharfstein, maha hussain, Margaret Hamburg, Prostate Cancer, provenge, Richard Pazdur, sloan kettering
Posted in The Cause, The Dysfunctional FDA | Post a Comment »
CareToLive Files Complaint Against FDA for Violation of Freedom of Information Act
January 2nd, 2008 | Posted by CTLNow comes Plaintiff CareToLive, a not for profit corporation and advocacy group organized and incorporated under the laws of and in Ohio, and hereby asserts the following causes of action against the Defendant, Food and Drug Administration (FDA), commissioner Andrew von Eschenbach.
Complaint Against the FDA for Violation of Freedom of Information Act (click link)
CareToLive is asking the public to help get to the bottom of the Provenge debacle by joining Congressmen Mike Michaud of Maine, Dan Burton of Indiana, and Tim Ryan of Ohio, who are calling for a congressional hearing into what happened. Contact your elected officials to ask for a congressional hearing, visiting the CareToLive website, dig our blogs, and join in the battle.
30,000 American men will die each year (not to mention the rest of the world) without this safe and effective immunotherapy. 1 in 6 men will get prostate cancer int heir lifetime. The FDA’s delay of Provenge was unprecedented in a terminal disease with an overwhelmingly positive panel that showed survival advantages, where no other options exist. Only one treatment for prostate cancer has been approved in 42 years. Send a clear message to Congress, the dysfunctional FDA, Wall Street, and the Chemo Cartel that we want this nontoxic immunotherapy approved NOW! More than 10 years of trials have shown it increases survival. Some men are alive as long as 6 years.
CONGRESSIONAL LETTER ASKING FOR A HEARING PDF (click here) Please fax this letter to your own congressional representatives and ask them to join this action. TIA
An Easy Way To Contact Your Elected Officials - (click here) EVERY VOICE COUNTS!
Continue Reading CareToLive Files Complaint Against FDA for Violation of Freedom of Information Act »
Popularity: 8%
Tags: , Andrew Von Eschenbach, Brachytherapy, Care To Live, CareToLive, Dendreon, FDA, foia, Freedom of Information Act, Kerry Donahue, Prostate Cancer, provenge, sloan kettering, taxotere
Posted in The Cause | 1 Comment »
Proquest Tries to Cover Its Tracks over Scher Provenge Debacle
January 2nd, 2008 | Posted by CTLWe are hot on the trail of the miscreants that derailed Provenge, a safe and effective immunotherapy for prostate cancer, condemning 30,000 American men to death without hope, in order to reap windfall profits.
Ed Silverman of Pharmalot reports on the shenanigans. (click link)
They may have taken down the links but we have the Proquest Investments 2007 Scientific Advisory Committee on our CareToLive research page showing the connections to Howard Scher and Milken’s Prostate Cancer Foundation that claims they want faster cures, yet remained mum on the Provenge Debacle. 3 Congressment are now calling for a Congressional hearing.
See our prior blog on Michael Milken’s Prostate Cancer Foundation and The Proquest Investment Fund / Howard Scher /FDA Unholy Alliance.(click link)
CareToLive is asking the public to help get to the bottom of the Provenge debacle by joining Congressmen Mike Michaud of Maine, Dan Burton of Indiana, and Tim Ryan of Ohio, who are calling for a congressional hearing into what happened. Contact your elected officials to ask for a congressional hearing, visiting the CareToLive website, dig our blogs, and join in the battle.
30,000 American men will die each year (not to mention the rest of the world) without this safe and effective immunotherapy. 1 in 6 men will get prostate cancer int heir lifetime. The FDA’s delay of Provenge was unprecedented in a terminal disease with an overwhelmingly positive panel that showed survival advantages, where no other options exist. Only one treatment for prostate cancer has been approved in 42 years. Send a clear message to Congress, the dysfunctional FDA, Wall Street, and the Chemo Cartel that we want this nontoxic immunotherapy approved NOW! More than 10 years of trials have shown it increases survival. Some men are alive as long as 6 years.
CONGRESSIONAL LETTER ASKING FOR A HEARING PDF (click here) Please fax this letter to your own congressional representatives and ask them to join this action. TIA
Continue Reading Proquest Tries to Cover Its Tracks over Scher Provenge Debacle »
Popularity: 12%
Tags: Asentar, Brachytherapy, Care To Live, CareToLive, Dendreon, Ed Silverman, FDA, howard i scher, Immunotherapy, Jay Moorin, Michael Milken, novacea, PCF, Pharmalot, Proquest Investments, Prostate Cancer, Prostate Cancer Foundation, provenge, sloan kettering
Posted in The Dysfunctional FDA, The Lawsuit | 1 Comment »
That Stupid Clown At The Prostate Cancer Rally Is Dead Serious
January 1st, 2008 | Posted by CTLCareToLive Spokesperson Mike Kearney (VIDEO LINK)
Mr. Kearney has a horse in this race. He is genetically predisposed to prostate cancer having one uncle who died from it and another uncle currently undergoing brachytherapy. 1 in 6 men will get prostate cancer in their lifetime.
Click this link to go to blog on Dr. Noah Prostate and Video of DC Rally.
Three Lawmakers Give Terminal Cancer Patients Early Xmas Gift —Evelyn Pringles gives a good summary of the Provenge debacle. (click link)
To the Silly 66 and Company who dugg our blog, thanks for playing. Let’s make 2008 the Year of Provenge Approval. We wish everybody a Happy and Healthy New Year!
CareToLive is asking the public to help get to the bottom of the Provenge debacle by contacting their elected officials to ask for a congressional hearing, visiting the CareToLive website, digging our blogs, and joining in the battle. 30,000 American men will die each year (not to mention the rest of the world) without this safe and effective immunotherapy.
The FDA’s delay of Provenge was unprecedented in a terminal disease with an overwhelmingly positive panel that showed survival advantages, where no other options exist. Only one treatment for prostate cancer has been approved in 42 years.Send a clear message to Congress, the dysfunctional FDA, Wall Street, and the Chemo Cartel that we want this nontoxic immunotherapy approved NOW! More than 10 years of trials have shown it increases survival. Some men are alive as long as 6 years.
Congressmen Mike Michaud of Maine, Dan Burton of Indiana, and Tim Ryan of Ohio are calling for a congressional hearing into what happened. We must continue to be vigilant and to contact our representatives in the Congress to keep the pressure on, and to demand a congressional hearing.
CONGRESSIONAL LETTER ASKING FOR A HEARING PDF (click here) Please fax this letter to your own congressional representatives and ask them to join this action. TIA
This link will take you right to a page to send a form to the committee Continue Reading That Stupid Clown At The Prostate Cancer Rally Is Dead Serious »
Popularity: 7%
Tags: Brachytherapy, Care To Live, CareToLive, Dendreon, FDA, Immunotherapy, Prostate Cancer, provenge, Richard Pazdur, sloan kettering, taxotere
Posted in The Cause | 5 Comments »